Assessment of Medovaha Srotasa Dushti Lakshana in non-alcoholic fatty liver disease (NAFLD): A Cross-Sectional Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 213
- 试验地点
- 1
- 主要终点
- Prevalence of Medovaha Srotasa Dushti Lakshana in patients diagnosed with non-
研究概览
简要总结
Roga Pariksha (disease examination) is a core element of Ayurvedic diagnosis. However, in the context of Yakrit Vikara (liver disorders), Ayurvedic literature offers very limited information mainly discussing Yakritdalyudara, which is insufficient for diagnosing complex modern liver diseases like Non-Alcoholic Fatty Liver Disease (NAFLD). This research emphasizes the need to bridge the knowledge gap between classical Ayurvedic texts and modern hepatology by studying symptoms through the lens of Srotasa Dushti Lakshana (channel vitiation) and Dhatu Dushti Lakshana (tissue vitiation). The study aims to develop a reliable diagnostic framework (Lakshan Samuchaya) for Yakrit Vikara Pariksha, focusing especially on Medovaha Srotasa Dushti, which aligns with NAFLD, given that Medo Dushti (fat tissue disorder) manifests as conditions like Sthoulya (obesity) and Prameha (diabetes) both key risk factors for NAFLD.
Considering the growing public health burden of liver diseases in India, and limited Ayurvedic references to Yakrit Vikara, this work seeks to Compile and reinterpret scattered Ayurvedic information on liver diseases, Align classical concepts with modern diseases like NAFLD, Develop subjective and objective tools for accurate Ayurvedic diagnosis, Promote standardization in examination (same format and questions for all participants), Ultimately re-establish a comprehensive Ayurvedic understanding of NAFLD while staying true to classical principles.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20.00 Year(s) 至 65.00 Year(s)(—)
- 性别
- All
入选标准
- •Individuals.
- •20 to 65 years of age with already diagnosed non-alcoholic fatty liver disease irrespective of their gender, religion, caste, occupation, socio-economic status etc., who can in their full consciousness, give clear consent for the project.
排除标准
- •Known case of alcoholic fatty liver disease.
- •Patients with systemic diseases affecting multiple body systems and critically ill patients.
- •Pregnant and lactating women.
- •Individuals not willing to participate after information about the project or who do not give a complete response to the questionnaire.
- •Individuals with Liver transplant.
结局指标
主要结局
Prevalence of Medovaha Srotasa Dushti Lakshana in patients diagnosed with non-
时间窗: Outcome will be assessed/estimated at baseline on first visit
alcoholic fatty liver disease.
时间窗: Outcome will be assessed/estimated at baseline on first visit
Analyze the common Lakshana of Medovaha Srotasa Dushti and their severity in
时间窗: Outcome will be assessed/estimated at baseline on first visit
relation to NAFLD grading.
时间窗: Outcome will be assessed/estimated at baseline on first visit
次要结局
未报告次要终点
研究者
DR ANIL POPAT PAREKAR
Dr. G.D. Pol Foundations, YMT Ayurvedic Medical College & PG Institute, Kharghar.
